Good Clinical Practice (GCP) defines the principles for any clinical trial conducted with medicinal products. GCP has been introduced by ICH (International Council on Harmonization) in 1997 and was just recently revised.
This interactive workshop seminar by the trainers Christoph Ortland and Doris Greiling from the Forschungsdock GmbH from Schenefeld near Hamburg included presentations with a lot of practical examples as well as workshops on principles and tools of GCP.
Christoph and Doris focused on the responsibilities of the study sponsor (e.g. as pharmaceutical or biotech company) but did also cover such elements that are of importance for the investigational team at the study site, i.e. at the hospital or private practice.
Thereby, eleven attendees got an excellent overview and a compact orientation about the ethical and scientific basis for the planning, preparation, conduct and reporting of clinical trials.
The course was directed to staff from pharmaceutical or biotech companies starting or planning to start clinical development programs having no or little experience with the current GCP requirements and to natural scientists, PhD students and Postdocs of natural scientific and medical degree programs being interested in getting an overview on GCP.
At the end of this intensive one-day course, the group has developed a basic understanding of GCP requirements in clinical trials with medicinal products - and is able also to identify potential occupational fields in the industry dealing with GCP topics.
The GLA and the trainers are proud that the course was evaluated by all 11 attendees as “very good” and that everybody would recommend this workshop to others.
The positive feedbacks such as “very interactive”, “high competence of trainers”, “learned a lot” and “super cool” encourage the trainers and the GLA to repeat this workshop next year, i.e. on 07 Dec 2020, 9:00 am – 5:00 pm.
This workshop can already be booked now at
Dr. Uwe Lohmeier per E-Mail:email@example.com
Photo: Campus Berlin-Buch GmbH